Solid Biosciences (SLDB) Current Leases (2018 - 2026)

Solid Biosciences (SLDB) has 9 years of Current Leases data on file, last reported at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 17.13% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (up 17.13% YoY), and the FY2025 full-year result was $2.1 million, up 70.84% from the prior year.
• Current Leases grew to $2.2 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.2 million in Q1 2026 to a low of $33000.0 in Q2 2022.
• A 5-year average of $1.2 million and a median of $1.1 million in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases plunged 97.8% in 2022 and jumped 5515.15% in 2023, its largest moves.
• Tracing SLDB's Current Leases over 5 years: stood at $668000.0 in 2022, then soared by 177.69% to $1.9 million in 2023, then plunged by 33.64% to $1.2 million in 2024, then surged by 70.84% to $2.1 million in 2025, then advanced by 4.04% to $2.2 million in 2026.
• Business Quant data shows SLDB's Current Leases at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $281000.0 in Q3 2025.